Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Outset Medical (OM) Cost of Revenue (2019 - 2025)

Outset Medical (OM) has disclosed Cost of Revenue for 7 consecutive years, with -$1.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Cost of Revenue fell 108.37% to -$1.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.3 million, a 32.9% decrease, with the full-year FY2025 number at $54.4 million, down 27.64% from a year prior.
  • Cost of Revenue was -$1.7 million for Q4 2025 at Outset Medical, down from $17.8 million in the prior quarter.
  • In the past five years, Cost of Revenue ranged from a high of $52.9 million in Q4 2021 to a low of -$1.7 million in Q4 2025.
  • A 5-year average of $21.5 million and a median of $20.5 million in 2022 define the central range for Cost of Revenue.
  • Peak YoY movement for Cost of Revenue: skyrocketed 160.64% in 2021, then crashed 108.37% in 2025.
  • Outset Medical's Cost of Revenue stood at $52.9 million in 2021, then tumbled by 36.48% to $33.6 million in 2022, then plummeted by 47.49% to $17.7 million in 2023, then increased by 16.32% to $20.5 million in 2024, then plummeted by 108.37% to -$1.7 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Cost of Revenue are -$1.7 million (Q4 2025), $17.8 million (Q3 2025), and $19.6 million (Q2 2025).